Brief: INmune Bio Announces Novel MRI Biomarker Data Demonstrating Improvement In Gray Matter In Patients With Alzheimer’S Disease
11/07/2023 13:57
July 11 (Reuters) - INmune Bio Inc INMB.O :
* INMUNE BIO INC. ANNOUNCES NOVEL MRI BIOMARKER DATA
DEMONSTRATING
IMPROVEMENT IN GRAY MATTER IN PATIENTS WITH ALZHEIMER’S DISEASE
Source text for Eikon: ID:nGNX37CCCD
Further company coverage: INMB.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Inmune Bio
See all newsBrief: Inmune Bio - Enters Master Services Agreement With Uniphar For Ebstrocel International Commercialization
Brief: Inmune Bio Targets UK Maa In Q4 2026, EU Maa And US BLA In Q1 2027
INmune Bio Inc reports results for the quarter ended June 30 - Earnings Summary
INmune Bio Q2 net loss narrows on lower impairment charges
INmune Bio Inc expected to post a loss of 21 cents a share - Earnings Preview